Oxford BioDynamics (Oxford BioDynamics) Net Income (Continuing Operations) : $-13.29 Mil (TTM As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Oxford BioDynamics Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Oxford BioDynamics's Net Income (Continuing Operations) for the six months ended in Sep. 2023 was $-7.90 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Sep. 2023 was $-13.29 Mil.

Oxford BioDynamics Net Income (Continuing Operations) Historical Data

The historical data trend for Oxford BioDynamics's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioDynamics Net Income (Continuing Operations) Chart

Oxford BioDynamics Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Net Income (Continuing Operations)

Get a 7-Day Free Trial

-3.47

-5.63

-9.18

-7.60

-13.40

Oxford BioDynamics Semi-Annual Data
	Sep13	Sep14	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Net Income (Continuing Operations)	Get a 7-Day Free Trial														-4.95	-3.81	-4.33	-5.39	-7.90

Oxford BioDynamics Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-13.29 Mil.

Oxford BioDynamics (OTCPK:OXBOF) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Oxford BioDynamics Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Oxford BioDynamics's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford BioDynamics (Oxford BioDynamics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioDynamics PLC (OTCPK:OXBOF) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

OBD:UK

Address

Oxford Business Park South, 3140 Rowan Place, John Smith Drive, Oxford, GBR, OX4 2WB

Website

https://www.oxfordbiodynamics.com

Oxford BioDynamics PLC is a biotechnology company. The company focuses on the discovery and development of biomarkers for use within the pharmaceutical and biotechnology industry. It provides a technology platform Episwitch which aims to accelerate the drug discovery and development process and improve the success rate of therapeutic product development. Geographically, the majority of revenue is from The United Kingdom.